logo
PROVIDERS
LABS
CROs
PAYORS
PATIENTS
ABOUT US
Schedule a Demo
Contact Us
Providers Oncology
scientists image
Overview

Transform Oncology Care with Precision AI

Personalized cancer treatment recommendations to optimize outcomes, reduce toxicity, and empower your oncology teams.
Schedule a Demo Contact us
Overview
Cancer therapy is complex, multifaceted, and highly personalized—every patient’s genetic makeup can influence drug efficacy and risk of severe adverse events. PGxAI’s Oncology module (PGxAstraea™) merges cutting-edge pharmacogenomics with real-world clinical data to help oncologists and health systems make informed decisions at every step of cancer treatment.
•
70+ oncology drugs covered, including chemotherapy, targeted therapies, immunomodulators, and hormonal agents.
•
46 critical genetic markers integrated for nuanced, patient-specific insights.
•
Generative AI that refines treatment recommendations in real time, reducing adverse reactions and improving survival rates.
Key Highlights
Serving every stakeholder in healthcare
Schedule a Demo Contact Us
1
icon
Comprehensive Drug-Gene Database
From platinum-based regimens (Cisplatin, Carboplatin) to targeted therapies (Erlotinib, Nilotinib), PGxAI provides actionable insights across a wide range of oncology treatments.
2
icon
Real-World Evidence & Machine Learning
Our platform continuously learns from clinical outcomes across multiple facilities, ensuring the most up-to-date evidence for your oncology team.
3
icon
Minimized Toxicity, Optimized Efficacy
Predictive analytics help clinicians tailor dosages, avoid harmful drug interactions, and select the most effective regimens for each patient’s genetic profile.
4
icon
Scalable for Health Systems
Designed for quick adoption across multiple sites, PGxAI fits seamlessly into existing oncology workflows, from small clinics to expansive hospital networks.
5
icon
Reimbursable Testing & Analysis
Our pharmacogenomic tests align with recognized CPT codes, simplifying billing and improving the cost-effectiveness of personalized cancer care.
Clinical Impact
Serving every stakeholder in healthcare
Schedule a Demo Contact Us
Reduce Readmissions
Targeted therapy selection and dose optimization lower the likelihood of serious adverse events, cutting unplanned hospital stays and ER visits.
Enhance Patient Satisfaction
Patients experience fewer side effects and more rapid therapeutic responses, fostering trust in their oncology care team.
Boost Operational Efficiency
By integrating drug-gene insights directly into the EHR, oncologists save time on trial-and-error prescribing, freeing up resources for deeper patient engagement.
Elevate Quality Metrics
PGxAI aligns with value-based care initiatives, improving quality scores (e.g., reducing complications and re-hospitalizations), which can lead to better reimbursement rates and institutional reputation.
Drug Categories
PGxAI supports a broad spectrum of oncology treatments
Schedule a Demo Contact Us
Chemotherapy Agents:
Doxorubicin, Fluorouracil, Cyclophosphamide, etc.
Targeted Therapies:
Gefitinib, Nilotinib, Erdafitinib.
Hormonal Therapies:
Tamoxifen, Anastrozole, Exemestane.
Platinum-Based Regimens:
Cisplatin, Carboplatin, Oxaliplatin.
Immunomodulators & Epigenetic Drugs:
Sacituzumab Govitecan, Belinostat, Irinotecan. Each recommendation is backed by a robust AI engine that considers genetic variants, molecular data, and published clinical evidence.
Integration
Seamless EHR Integration
PGxAI is pre-built for interoperability with leading EHR systems like Epic, Cerner, Allscripts, and more. Through our partnership with InterSystems IRIS for Health, oncology teams gain real-time PGx insights right in their workflow. No more juggling multiple portals or standalone apps—just instant, actionable data when you need it most.
icon
Security
HIPAA & SOC 2 compliance ensures patient privacy and data integrity.
icon
Automations
Automated alerts for high-risk gene-drug interactions.
icon
Analytics
Customizable dashboards for oncology pharmacists, oncologists, and care coordinators.
Case Study
Midtown Oncology Center
Schedule a Demo Contact Us
icon
Challenge
High rates of toxic side effects in metastatic breast cancer patients on combination chemotherapy, leading to repeated ED visits.
icon
Solution
PGxAI deployed to analyze each patient’s genetic markers and identify optimal dosing regimens.
icon
Results
28% drop in treatment-related hospital admissions over 6 months, improved patient satisfaction scores, and streamlined pharmacy management.
“PGxAI helped us identify and address genetic variants causing severe toxicity in our patient population. Our readmission rates have never been lower.”
human image
Dr. Maria Thompson
Oncology Department Lead
Whats next
Ready to Shape the Future of Precision Medicine?
Empower your oncology department with a platform that maximizes patient outcomes and minimizes complications. Experience how precision genomics can transform cancer care across your health system.
Contact Our Oncology Team
Get in touch for customization options, EHR integration details, or pilot programs.
icon
Request a Demo
Schedule a personalized walkthrough of PGxAI’s Oncology module.
icon
Learn More About EHR Integration
Explore how PGxAI fits seamlessly into your existing infrastructure.
icon